Christopher N. Batuello, Ph.D.
Affiliations: | 2012 | Biochemistry and Molecular Biology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Molecular Biology, Biochemistry, General BiologyGoogle:
"Christopher Batuello"Parents
Sign in to add mentor| Lindsey D. Mayo | grad student | 2012 | Indiana University | |
| (Phospho-regulation and metastatic potential of murine double minute 2.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hauck P, Wolf E, Olivos D, et al. (2017) Early Stage Metastasis require Mdm2 and not p53 Gain of Function. Molecular Cancer Research : McR |
| Tonsing-Carter E, Bailey BJ, Saadatzadeh MR, et al. (2015) Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model. Molecular Cancer Therapeutics |
| Batuello CN, Hauck PM, Gendron JM, et al. (2015) Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase. Proceedings of the National Academy of Sciences of the United States of America. 112: 1749-54 |
| Lehman JA, Hauck PM, Gendron JM, et al. (2013) Serdemetan antagonizes the Mdm2-HIF1α axis leading to decreased levels of glycolytic enzymes. Plos One. 8: e74741 |
| Lehman JA, Waning DL, Batuello CN, et al. (2011) Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress. The Journal of Biological Chemistry. 286: 36631-40 |
| Waning DL, Lehman JA, Batuello CN, et al. (2011) c-Abl phosphorylation of Mdm2 facilitates Mdm2-Mdmx complex formation. The Journal of Biological Chemistry. 286: 216-22 |
| Waning DL, Lehman JA, Batuello CN, et al. (2010) Controlling the Mdm2-Mdmx-p53 Circuit. Pharmaceuticals (Basel, Switzerland). 3: 1576-1593 |
| Araki S, Eitel JA, Batuello CN, et al. (2010) TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. The Journal of Clinical Investigation. 120: 290-302 |
| Lehman JA, Eitel JA, Batuello CN, et al. (2008) Therapeutic considerations for Mdm2: not just a one trick pony. Expert Opinion On Drug Discovery. 3: 1309-1321 |